99mtc ethylenedicysteine-deoxyglucose
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2010 (NCT00864110)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 89-zirconium
Oral
No
Parenteral
No
Topical
No
Also known as
- 99mtc ethylenedicysteine-deoxyglucose
- 99mtc ethylenedicysteine-deoxyglucose
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00864110 | Phase 1 | Apr 1, 2010 | Camargo Pharmaceutical Services, Cell>Point LLC, Numoda, Venn Life Sciences, Yeshiva University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Camargo Pharmaceutical Services | For profit | 1 | 0 | 1 | 2010 |
| Cell>Point LLC | For profit | 1 | 1 | 1 | 2010 |
| Numoda | For profit | 1 | 0 | 1 | 2010 |
| Venn Life Sciences | For profit | 1 | 0 | 1 | 2010 |
| Yeshiva University | Academic/Hospital | 1 | 0 | 1 | 2010 |
5 organizations
Page 1 / 1